Literature DB >> 21555004

Osteoblast/osteocyte-specific inactivation of Stat3 decreases load-driven bone formation and accumulates reactive oxygen species.

Hongkang Zhou1, America B Newnum, Joseph R Martin, Ping Li, Mark T Nelson, Akira Moh, Xin-Yuan Fu, Hiroki Yokota, Jiliang Li.   

Abstract

Signal transducers and activators of transcription 3 (Stat3) is a transcription factor expressed in many cell types including osteoblasts, osteocytes, and osteoclasts. STAT3 mutations cause a rare human immunodeficiency disease that presents reduced bone mineral density and recurrent pathological fractures. To investigate the role of Stat3 in load-driven bone metabolism, two strains of osteoblast/osteocyte-selective Stat3 knockout (KO) mice were generated. Compared to age-matched littermate controls, this selective inactivation of Stat3 significantly lowered bone mineral density (7-12%, p<0.05) as well as ultimate force (21-34%, p<0.01). In ulna loading (2.50-2.75N with 120 cycles/day at 2Hz for 3 consecutive days), Stat3 KO mice were less responsive than littermate controls as indicated by reduction in relative mineralizing surface (rMS/BS, 47-59%, p<0.05) and relative bone formation rate (rBFR/BS, 64-75%, p<0.001). Furthermore, inactivation of Stat3 suppressed load-driven mitochondrial activity, which led to an elevated level of reactive oxygen species (ROS) in cultured primary osteoblasts. Taken together, the results support the notion that the loss-of-function mutation of Stat3 in osteoblasts and osteocytes diminishes load-driven bone formation and impairs the regulation of oxidative stress in mitochondria.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21555004     DOI: 10.1016/j.bone.2011.04.020

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  43 in total

1.  STAT3 controls osteoclast differentiation and bone homeostasis by regulating NFATc1 transcription.

Authors:  Yiling Yang; Mi Ri Chung; Siru Zhou; Xinyi Gong; Hongyuan Xu; Yueyang Hong; Anting Jin; Xiangru Huang; Weiguo Zou; Qinggang Dai; Lingyong Jiang
Journal:  J Biol Chem       Date:  2019-08-28       Impact factor: 5.157

2.  mTORC1 Plays an Important Role in Skeletal Development by Controlling Preosteoblast Differentiation.

Authors:  Stephen Fitter; Mary P Matthews; Sally K Martin; Jianling Xie; Soo Siang Ooi; Carl R Walkley; John D Codrington; Markus A Ruegg; Michael N Hall; Christopher G Proud; Stan Gronthos; Andrew C W Zannettino
Journal:  Mol Cell Biol       Date:  2017-03-17       Impact factor: 4.272

3.  The expression of Fn14 via mechanical stress-activated JNK contributes to apoptosis induction in osteoblasts.

Authors:  Hiroyuki Matsui; Naoto Fukuno; Yoshiaki Kanda; Yusuke Kantoh; Toko Chida; Yuko Nagaura; Osamu Suzuki; Hideki Nishitoh; Kohsuke Takeda; Hidenori Ichijo; Yasuhiro Sawada; Keiichi Sasaki; Takayasu Kobayashi; Shinri Tamura
Journal:  J Biol Chem       Date:  2014-01-20       Impact factor: 5.157

4.  MeCP2 reinforces STAT3 signaling and the generation of effector CD4+ T cells by promoting miR-124-mediated suppression of SOCS5.

Authors:  Shan Jiang; Chaoran Li; Gabrielle McRae; Erik Lykken; Jose Sevilla; Si-Qi Liu; Ying Wan; Qi-Jing Li
Journal:  Sci Signal       Date:  2014-03-11       Impact factor: 8.192

5.  Dual roles of QOA-8a in antiosteoporosis: a combination of bone anabolic and anti-resorptive effects.

Authors:  Jing Wu; Qi Shen; Wei Cui; Yu Zhao; Yue Huai; Yu-Chao Zhang; Bei-Hua Bao; Chen-Xi Liu; Qing Jiang; Jian-Xin Li
Journal:  Acta Pharmacol Sin       Date:  2017-08-17       Impact factor: 6.150

6.  Prevention of murine lupus nephritis by targeting multiple signaling axes and oxidative stress using a synthetic triterpenoid.

Authors:  Tianfu Wu; Yujin Ye; So-Youn Min; Jiankun Zhu; Elhaum Khobahy; Jason Zhou; Mei Yan; Sriram Hemachandran; Simanta Pathak; Xin J Zhou; Michael Andreeff; Chandra Mohan
Journal:  Arthritis Rheumatol       Date:  2014-11       Impact factor: 10.995

7.  Mechanosensor polycystin-1 potentiates differentiation of human osteoblastic cells by upregulating Runx2 expression via induction of JAK2/STAT3 signaling axis.

Authors:  Georgia Dalagiorgou; Christina Piperi; Christos Adamopoulos; Urania Georgopoulou; Antonios N Gargalionis; Anastasia Spyropoulou; Ilianna Zoi; Marjan Nokhbehsaim; Anna Damanaki; James Deschner; Efthimia K Basdra; Athanasios G Papavassiliou
Journal:  Cell Mol Life Sci       Date:  2016-10-03       Impact factor: 9.261

Review 8.  Understanding and targeting osteoclastic activity in prostate cancer bone metastases.

Authors:  J L Sottnik; E T Keller
Journal:  Curr Mol Med       Date:  2013-05       Impact factor: 2.222

9.  Loss of STAT3 in mouse embryonic fibroblasts reveals its Janus-like actions on mitochondrial function and cell viability.

Authors:  Fouad A Zouein; Roy J Duhé; Istvan Arany; Kristin Shirey; Jonathan P Hosler; Huiling Liu; Iman Saad; Mazen Kurdi; George W Booz
Journal:  Cytokine       Date:  2013-12-31       Impact factor: 3.861

10.  Adaptive and Injury Response of Bone to Mechanical Loading.

Authors:  Sarah H McBride; Matthew J Silva
Journal:  Bonekey Osteovision       Date:  2012-10-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.